Skip to main content

Advertisement

Log in

The protean ocular involvement in monogenic autoinflammatory diseases: state of the art

  • Review Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Ocular involvement is frequent in the monogenic autoinflammatory disorders and generally occurs as spontaneously recurring inflammatory events at different ocular sites caused by the aberrant release of proinflammatory cytokines, mainly IL-1β. Over the past decade, we witnessed a significant growth of eye abnormalities associated with idiopathic granulomatous disorders, familial Mediterranean fever, tumor necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and cryopyrin-associated periodic syndrome. The pathogenetic mechanisms of these disorders have shown the evidence of disrupted cytokine signaling, but the explanation for the heterogeneous ocular involvement remains to be elucidated. We herein review the monogenic autoinflammatory disorders affecting the eye, describing their main clinical features with specific regard to the ocular involvement, which can lead to decreased visual acuity and even blindness, if the primary disorder is undetected or left untreated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Kastner DL, Aksentijevich I, Goldbach-Mansky R (2010) Autoinflammatory disease reloaded: a clinical perspective. Cell 140:784–790

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Rigante D, Vitale A, Lucherini OM, Cantarini L (2014) The hereditary autoinflammatory disorders uncovered. Autoimmun Rev 13:892–900

    Article  CAS  PubMed  Google Scholar 

  3. Rigante D, Frediani B, Galeazzi M, Cantarini L (2013) From the Mediterranean to the sea of Japan: the transcontinental odyssey of autoinflammatory diseases. Biomed Res Int 2013:485103

    Article  PubMed Central  PubMed  Google Scholar 

  4. Muscari I, Iacoponi F, Cantarini L, Lucherini OM, Simonini G, Brizi MG et al (2012) The diagnostic evaluation of patients with potential adult-onset autoinflammatory disorders: our experience and review of the literature. Autoimmun Rev 12:10–13

    Article  PubMed  Google Scholar 

  5. Sayarlioglu M, Cefle A, Inanc M, Kamali S, Dalkilic E, Gul A et al (2005) Characteristics of patients with adult-onset familial Mediterranean fever in Turkey: analysis of 401 cases. Int J Clin Pract 59:202–205

    Article  CAS  PubMed  Google Scholar 

  6. Cantarini L, Iacoponi F, Lucherini OM, Obici L, Brizi MG, Cimaz R et al (2011) Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults. Int J Immunopathol Pharmacol 24:695–702

    PubMed  Google Scholar 

  7. Cantarini L, Vitale A, Lucherini OM, De Clemente C, Caso F, Costa L et al (2015) The labyrinth of autoinflammatory disorders: a snapshot on the activity of a third-level center in Italy. Clin Rheumatol 34:17–28

    Article  PubMed  Google Scholar 

  8. Cantarini L, Rigante D, Brizi MG, Lucherini OM, Sebastiani GD, Vitale A et al (2012) Clinical and biochemical landmarks in systemic autoinflammatory diseases. Ann Med 44:664–673

    Article  PubMed  Google Scholar 

  9. Rigante D (2010) The protean visage of systemic autoinflammatory syndromes: a challenge for inter-professional collaboration. Eur Rev Med Pharmacol Sci 14:1–18

    CAS  PubMed  Google Scholar 

  10. Cantarini L, Lucherini OM, Cimaz R, Baldari CT, Laghi Pasini F, Galeazzi M (2010) Sacroileitis and pericarditis: atypical presentation of tumor necrosis factor receptor-associated periodic syndrome and response to etanercept therapy. Clin Exp Rheumatol 28:290–291

    CAS  PubMed  Google Scholar 

  11. Rigante D, Cantarini L, Imazio M, Lucherini OM, Sacco E, Galeazzi M et al (2011) Autoinflammatory diseases and cardiovascular manifestations. Ann Med 43:341–346

    Article  CAS  PubMed  Google Scholar 

  12. Cantarini L, Imazio M, Brizi MG, Lucherini OM, Brucato A, Cimaz R et al (2013) Role of autoimmunity and autoinflammation in the pathogenesis of idiopathic recurrent pericarditis. Clin Rev Allergy Immunol 44:6–13

    Article  CAS  PubMed  Google Scholar 

  13. Cantarini L, Lucherini OM, Iacoponi F, Cimaz R, Simonini G, Rigante D et al (2010) Development and preliminary validation of a diagnostic score for identifying patients affected with adult-onset autoinflammatory disorders. Int J Immunopathol Pharmacol 23:1133–1141

    CAS  PubMed  Google Scholar 

  14. Cantarini L, Lopalco G, Selmi C, Napodano S, De Rosa G, Caso F et al (2015) Autoimmunity and autoinflammation as the yin and yang of idiopathic recurrent acute pericarditis. Autoimmun Rev 14:90–97

    Article  CAS  PubMed  Google Scholar 

  15. Lachmann HJ, Hawkins PN (2009) Developments in the scientific and clinical understanding of autoinflammatory disorders. Arthritis Res Ther 11:212

    Article  PubMed Central  PubMed  Google Scholar 

  16. Cantarini L, Rigante D, Brizi MG, Sebastiani GD, Lucherini OM, Galeazzi M et al (2011) The laboratory approach in the diagnosis of systemic autoinflammatory diseases. Reumatismo 63:101–110

    Article  CAS  PubMed  Google Scholar 

  17. Ter Haar N, Lachmann H, Özen S, Woo P, Uziel Y, Modesto C et al (2013) Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review. Ann Rheum Dis 72:678–685

    Article  PubMed  Google Scholar 

  18. Vitale A, Rigante D, Lucherini OM, Caso F, Muscari I, Magnotti F et al (2013) Biological treatments: new weapons in the management of monogenic autoinflammatory disorders. Mediators Inflamm 2013:939847. doi:10.1155/2013/939847

    PubMed Central  PubMed  Google Scholar 

  19. Blau EB (1985) Familial granulomatous arthritis, iritis, and rash. J Pediatr 107:689–693

    Article  CAS  PubMed  Google Scholar 

  20. Caso F, Costa L, Rigante D, Vitale A, Cimaz R, Lucherini OM et al (2014) Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis. Autoimmun Rev 13:1220–1229

    Article  PubMed  Google Scholar 

  21. Villanueva-Mendoza C, Arellanes-García L, Cubas-Lorenzo V, Jimenez-Martinez MC, Flores-Suárez LF, Zenteno JC (2010) Familial case of Blau syndrome associated with a CARD15/NOD2 mutation. Ophthalmic Genet 31:155–158

    Article  CAS  PubMed  Google Scholar 

  22. Miceli-Richard C, Lesage S, Rybojad M, Prieur AM, Manouvrier-Hanu S, Häfner R et al (2001) CARD15 mutations in Blau syndrome. Nat Genet 29:19–20

    Article  CAS  PubMed  Google Scholar 

  23. La Torre F, Lapadula G, Cantarini L, Lucherini OM, Iannone F (2015) Early-onset sarcoidosis caused by a rare CARD15/NOD2 de novo mutation and responsive to infliximab: a case report with long-term follow-up and review of the literature. Clin Rheumatol 34:391–395

    Article  PubMed  Google Scholar 

  24. Martin TM, Zhang Z, Kurz P, Rosé CD, Chen H, Lu H et al (2009) The NOD2 defect in Blau syndrome does not result in excess interleukin-1 activity. Arthritis Rheum 60:611–618

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  25. Sharma SM, Martin TM, Rosé CD, Dick AD, Ramanan AV (2011) Distinguishing between the innate immune response due to ocular inflammation and infection in a child with juvenile systemic granulomatous disease treated with anti-TNF-α monoclonal antibodies. Rheumatology (Oxford) 50:990–992

    Article  Google Scholar 

  26. Latkany PA, Jabs DA, Smith JR, Rosenbaum JT, Tessler H, Schwab IR et al (2002) Multifocal choroiditis in patients with familial juvenile systemic granulomatosis. Am J Ophthalmol 134:897–904

    Article  PubMed  Google Scholar 

  27. Carreño E, Guly CM, Chilov M, Hinchcliffe A, Arostegui JI, Lee RW et al (2014) Optic nerve and retinal features in uveitis associated with juvenile systemic granulomatous disease (Blau syndrome). Acta Ophthalmol. doi:10.1111/aos.12544

    PubMed  Google Scholar 

  28. Aróstegui JI, Arnal C, Merino R, Modesto C, Antonia Carballo M, Moreno P et al (2007) NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort. Arthritis Rheum 56:3805–3813

    Article  PubMed  Google Scholar 

  29. Milhavet F, Cuisset L, Hoffman HM, Slim R, El-Shanti H, Aksentijevich I et al (2008) The infevers autoinflammatory mutation online registry: update with new genes and functions. Hum Mutat 29:803–808

    Article  PubMed  Google Scholar 

  30. Rigante D, La Torraca I, Avallone L, Pugliese AL, Gaspari S, Stabile A (2006) The pharmacologic basis of treatment with colchicine in children with familial Mediterranean fever. Eur Rev Med Pharmacol Sci 10:173–178

    CAS  PubMed  Google Scholar 

  31. Lidar M, Livneh A (2007) Familial Mediterranean fever: clinical, molecular and management advancements. Neth J Med 65:318–324

    CAS  PubMed  Google Scholar 

  32. Cantarini L, Capecchi PL, Lucherini OM, Laghi Pasini F, Galeazzi M (2010) Familial Mediterranean fever diagnosed in an elderly patient. Clin Exp Rheumatol 28:S91

    PubMed  Google Scholar 

  33. Michaelson I, Eliakim M, En E, Rachmilewitz M (1959) Fundal changes resembling colloid bodies in recurrent polyserositis (periodic disease). AMA Arch Ophthalmol 62:1–4

    Article  CAS  PubMed  Google Scholar 

  34. Yazici H, Pazarli H (1982) Eye involvement in a patient with familial Mediterranean fever. J Rheumatol 9:644

    CAS  PubMed  Google Scholar 

  35. Yazici A, Ozdal P, Yuksekkaya P, Elgin U, Teke MY, Sari E (2014) Ophthalmic manifestations in familial Mediterranean fever: a case series of 6 patients. Eur J Ophthalmol 24:593–598

    Article  PubMed  Google Scholar 

  36. Hirsh A, Huna R, Ashkenazi I, Bartov E, Blumenthal M (1990) Recurrent bilateral panuveitis and rhegmatogenous retinal detachment in a patient with familial Mediterranean fever. Am J Ophthalmol 110:702–703

    Article  CAS  PubMed  Google Scholar 

  37. Finsterer J, Stöllberger C, Shinar Y (2002) Cranial nerve lesions and abnormal visually evoked potentials associated with the M694V mutation in familial Mediterranean fever. Clin Rheumatol 21:317–321

    Article  CAS  PubMed  Google Scholar 

  38. Lossos A, Eliashiv S, Ben-Chetrit E, Reches A (1993) Optic neuritis associated with familial Mediterranean fever. J Clin Neuroophthalmol 13:141–143

    CAS  PubMed  Google Scholar 

  39. Rigante D, Lopalco G, Vitale A, Lucherini OM, De Clemente C, Caso F et al (2014) Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome. Clin Rheumatol 33:1197–1207

    Article  PubMed  Google Scholar 

  40. Magnotti F, Vitale A, Rigante D, Lucherini OM, Cimaz R, Muscari I et al (2013) The most recent advances in pathophysiology and management of tumour necrosis factor receptor-associated periodic syndrome (TRAPS): personal experience and literature review. Clin Exp Rheumatol 31(3 Suppl 77):141–149

    PubMed  Google Scholar 

  41. Cantarini L, Lucherini OM, Muscari I, Frediani B, Galeazzi M, Brizi MG et al (2012) Tumour necrosis factor receptor-associated periodic syndrome (TRAPS): state of the art and future perspectives. Autoimmun Rev 12:38–43

    Article  CAS  PubMed  Google Scholar 

  42. Cantarini L, Rigante D, Merlini G, Vitale A, Caso F, Lucherini OM et al (2014) The expanding spectrum of low-penetrance TNFRSF1A gene variants in adults presenting with recurrent inflammatory attacks: clinical manifestations and long-term follow-up. Semin Arthritis Rheum 43:818–823

    Article  CAS  PubMed  Google Scholar 

  43. Stojanov S, McDermott MF (2005) The tumour necrosis factor receptor-associated periodic syndrome: current concepts. Expert Rev Mol Med 7:1–18

    Article  PubMed  Google Scholar 

  44. Samuels J, Ozen S (2006) Familial Mediterranean fever and the other autoinflammatory syndromes: evaluation of the patient with recurrent fever. Curr Opin Rheumatol 18:108–117

    Article  PubMed  Google Scholar 

  45. Lachmann HJ, Papa R, Gerhold K, Obici L, Touitou I, Cantarini L et al (2014) The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry. Ann Rheum Dis 73:2160–2167. doi:10.1136/annrheumdis-2013-204184

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  46. Masson C, Simon V, Hoppé E, Insalaco P, Cissé I, Audran M (2004) Tumor necrosis factor receptor-associated periodic syndrome (TRAPS): definition, semiology, prognosis, pathogenesis, treatment, and place relative to other periodic joint diseases. Joint Bone Spine 71:284–290

    Article  PubMed  Google Scholar 

  47. Dodé C, André M, Bienvenu T, Hausfater P, Pêcheux C, Bienvenu J et al (2002) The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum 46:2181–2188

    Article  PubMed  Google Scholar 

  48. Haas SL, Lohse P, Schmitt WH, Hildenbrand R, Karaorman M, Singer MV et al (2006) Severe TNF receptor-associated periodic syndrome due to 2 TNFRSF1A mutations including a new F60V substitution. Gastroenterology 130:172–178

    Article  CAS  PubMed  Google Scholar 

  49. Trost S, Rose CD (2005) Myocarditis and sacroiliitis: 2 previously unrecognized manifestations of tumor necrosis factor receptor associated periodic syndrome. J Rheumatol 32:175–177

    PubMed  Google Scholar 

  50. Hurst M, Hull K, Nicholls D, Ameratunga R (2005) Hereditary periodic fever syndrome sans fever or distinct periodicity presenting with psychosis. J Clin Rheumatol 11:329–330

    Article  PubMed  Google Scholar 

  51. Rudofsky G, Hoffmann F, Muller K, Filser M, Lohse P, Beimler J et al (2006) A nephrotic patient with tumor necrosis factor receptor associated syndrome, IgA nephropathy and CNS involvement. Nephrol Dial Transplant 21:1109–1112

    Article  PubMed  Google Scholar 

  52. Toro JR, Aksentijevich I, Hull K, Dean J, Kastner DL (2000) Tumor necrosis factor receptor-associated periodic syndrome: a novel syndrome with cutaneous manifestations. Arch Dermatol 136:1487–1494

    CAS  PubMed  Google Scholar 

  53. Kümpfel T, Hoffmann LA, Rübsamen H, Pöllmann W, Feneberg W, Hohlfeld R et al (2007) Late-onset tumor necrosis factor receptor-associated periodic syndrome in multiple sclerosis patients carrying the TNFRSF1A R92Q mutation. Arthritis Rheum 56:2774–2783

    Article  PubMed  Google Scholar 

  54. Minden K, Aganna E, McDermott MF, Zink A (2004) Tumor necrosis factor receptor associated periodic syndrome (TRAPS) with central nervous system involvement. Ann Rheum Dis 63:1356–1357

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  55. Rösen-Wolff A, Kreth HW, Hofmann S, Höhne K, Heubner G, Möbius D et al (2001) Periodic fever (TRAPS) caused by mutations in the TNF-alpha receptor 1 (TNFRSF1A) gene of three German patients. Eur J Haematol 67:105–109

    Article  PubMed  Google Scholar 

  56. van der Burgh R, Ter Haar NM, Boes ML, Frenkel J (2013) Mevalonate kinase deficiency, a metabolic autoinflammatory disease. Clin Immunol 147:197–206

    Article  PubMed  Google Scholar 

  57. Houten SM, Wanders RJ, Waterham HR (2000) Biochemical and genetic aspects of mevalonate kinase and its deficiency. Biochim Biophys Acta 1529:19–32

    Article  CAS  PubMed  Google Scholar 

  58. Esposito S, Ascolese B, Senatore L, Bosis S, Verrecchia E, Cantarini L et al (2014) Current advances in the understanding and treatment of mevalonate kinase deficiency. Int J Immunopathol Pharmacol 27:491–498

    CAS  PubMed  Google Scholar 

  59. Cantarini L, Vitale A, Magnotti F, Lucherini OM, Caso F, Frediani B et al (2013) Weekly oral alendronate in mevalonate kinase deficiency. Orphanet J Rare Dis 8:196

    Article  PubMed Central  PubMed  Google Scholar 

  60. Prietsch V, Mayatepek E, Krastel H, Haas D, Zundel D, Waterham HR et al (2003) Mevalonate kinase deficiency: enlarging the clinical and biochemical spectrum. Pediatrics 111:258–261

    Article  PubMed  Google Scholar 

  61. Balgobind B, Wittebol-Post D, Frenkel J (2005) Retinitis pigmentosa in mevalonate kinase deficiency. J Inherit Metab Dis 28:1143–1145

    Article  CAS  PubMed  Google Scholar 

  62. Poll-The BT, de Buy M, Wenniger-Prick LJ, Barth PG, Duran M (2003) The eye as a window to inborn errors of metabolism. J Inherit Metab Dis 26:229–244

    Article  CAS  PubMed  Google Scholar 

  63. Fliesler SJ, Peachey NS, Richards MJ, Nagel BA, Vaughan DK (2004) Retinal degeneration in a rodent model of Smith-Lemli-Opitz syndrome: electrophysiologic, biochemical, and morphologic features. Arch Ophthalmol 122:1190–1200

    Article  PubMed Central  PubMed  Google Scholar 

  64. Yan D, Swain PK, Breuer D, Tucker RM, Wu W, Fujita R et al (1998) Biochemical characterization and subcellular localization of the mouse retinitis pigmentosa GTPase regulator (mRpgr). J Biol Chem 273:19656–19663

    Article  CAS  PubMed  Google Scholar 

  65. Hoffman HM, Wanderer AA, Broide DH (2001) Familial cold autoinflammatory syndrome: phenotype and genotype of an autosomal dominant periodic fever. J Allergy Clin Immunol 108:615–620

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  66. Vitale A, Lucherini OM, Galeazzi M, Frediani B, Cantarini L (2012) Long-term clinical course of patients carrying the Q703K mutation in the NLRP3 gene: a case series. Clin Exp Rheumatol 30:943–946

    PubMed  Google Scholar 

  67. Espandar L, Boehlke CS, Kelly MP (2014) First report of keratitis in familial cold autoinflammatory syndrome. Can J Ophthalmol 49:304–306

    Article  PubMed  Google Scholar 

  68. Muckle TJ, Wells M (1962) Urticaria, deafness, and amyloidosis: a new heredo-familial syndrome. Q J Med 31:235–248

    CAS  PubMed  Google Scholar 

  69. Lequerré T, Vittecoq O, Saugier-Veber P, Goldenberg A, Patoz P, Frébourg T et al (2007) A cryopyrin associated periodic syndrome with joint destruction. Rheumatology 46:709–714

    Article  PubMed  Google Scholar 

  70. Scarpioni R, Rigante D, Cantarini L, Ricardi M, Albertazzi V, Melfa L, et al (2014) Renal involvement in secondary amyloidosis of Muckle-Wells syndrome: marked improvement of renal function and reduction of proteinuria after therapy with human anti-interleukin-1β monoclonal antibody canakinumab. Clin Rheumatol

  71. Kitley JL, Lachmann HJ, Pinto A, Ginsberg L (2010) Neurologic manifestations of the cryopyrin-associated periodic syndrome. Neurology 74:1267–1270

    Article  CAS  PubMed  Google Scholar 

  72. Kawai M, Yoshikawa T, Nishikomori R, Heike T, Takahashi K (2013) Obvious optic disc swelling in a patient with cryopyrin-associated periodic syndrome. Clin Ophthalmol 7:1581–1585

    PubMed Central  PubMed  Google Scholar 

  73. Gorovoy IR, Gorovoy JB, Salomao D, Gorovoy MS (2013) Chronic keratitis with intrastromal epithelioid histiocytes: a new finding in Muckle-Wells syndrome. Cornea 32:510–512

    Article  PubMed  Google Scholar 

  74. Shakeel A, Gouws P (2007) Muckle-Wells syndrome: another cause of acute anterior uveitis. Eye (Lond) 21:849–850

    Article  CAS  Google Scholar 

  75. Cantarini L, Lucherini OM, Frediani B, Brizi MG, Bartolomei B, Cimaz R et al (2011) Bridging the gap between the clinician and the patient with cryopyrin-associated periodic syndromes. Int J Immunopathol Pharmacol 24:827–836

    CAS  PubMed  Google Scholar 

  76. Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN, Tschopp J (2004) NALP3 forms an IL-1β-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 20:319–325

    Article  CAS  PubMed  Google Scholar 

  77. Miyamae T (2012) Cryopyrin-associated periodic syndromes: diagnosis and management. Pediatric Drugs 14:109–117

    Article  PubMed  Google Scholar 

  78. Levy R, Gérard L, Kuemmerle-Deschner J, Lachmann HJ, Koné-Paut I, Cantarini L et al (2014) Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry. Ann Rheum Dis. doi:10.1136/annrheumdis-2013-204991

    Google Scholar 

  79. Prieur AM (2001) A recently recognised chronic inflammatory disease of early onset characterised by the triad of rash, central nervous system involvement and arthropathy. Clin Exp Rheumat 19:103–106

    CAS  Google Scholar 

  80. Rigante D, Ansuini V, Caldarelli M, Bertoni B, La Torraca I, Stabile A (2006) Hydrocephalus in CINCA syndrome treated with anakinra. Childs Nerv Syst 22:334–337

    Article  CAS  PubMed  Google Scholar 

  81. Hill SC, Namde M, Dwyer A, Poznanski A, Canna S, Goldbach-Mansky R (2007) Arthropathy of neonatal onset multisystem inflammatory disease (NOMID/CINCA). Pediatr Radiol 37:145–152

    Article  PubMed  Google Scholar 

  82. Dollfus H, Häfner R, Hofmann HM, Russo RA, Denda L, Gonzales LD et al (2000) Chronic infantile neurological cutaneous and articular/neonatal onset multisystem inflammatory disease syndrome: ocular manifestations in a recently recognized chronic inflammatory disease of childhood. Arch Ophthalmol 118:1386–1392

    Article  CAS  PubMed  Google Scholar 

  83. Sadiq SA, Gregson RM, Downes RN (1996) The CINCA syndrome: a rare cause of uveitis in childhood. J Pediatr Ophthalmol Strabismus 33:59–63

    CAS  PubMed  Google Scholar 

  84. Adán A, Solé M, Corcostegui B, Navarro R, Burés A (2009) Cytological vitreous findings in a patient with infantile neurological cutaneous and articular (CINCA) syndrome. BMJ Case Rep 2009. doi: 10.1136/bcr.09.2008.0992

  85. Terrada C, Neven B, Boddaert N, Souied EH, Prieur AM, Quartier P et al (2011) Ocular modifications in a young girl with cryopyrin-associated periodic syndromes responding to interleukin-1 receptor antagonist anakinra. J Ophthalmic Inflamm Infect 1:133–136

    Article  PubMed Central  PubMed  Google Scholar 

  86. Teoh SC, Sharma S, Hogan A, Lee R, Ramanan AV, Dick AD (2007) Tailoring biological treatment: anakinra treatment of posterior uveitis associated with the CINCA syndrome. Br J Ophthalmol 91:263–264

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  87. Rigante D, Stabile A, Minnella A, Avallone L, Ziccardi L, Bersani G et al (2010) Post-inflammatory retinal dystrophy in CINCA syndrome. Rheumatol Int 30:389–393

    Article  PubMed  Google Scholar 

  88. Khemani C, Khubchandani R (2007) CINCA syndrome. Indian Pediatr 44:933–936

    PubMed  Google Scholar 

  89. Russo RA, Katsicas MM (2001) Chronic infantile neurological cutaneous and articular syndrome: two new cases with rare manifestations. Acta Paediatr 90:1076–1079

    Article  CAS  PubMed  Google Scholar 

Download references

Disclosures

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Luca Cantarini.

Additional information

Vittoria Bascherini, Carmela Granato, Donato Rigante and Luca Cantarini contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bascherini, V., Granato, C., Lopalco, G. et al. The protean ocular involvement in monogenic autoinflammatory diseases: state of the art. Clin Rheumatol 34, 1171–1180 (2015). https://doi.org/10.1007/s10067-015-2920-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-015-2920-3

Keywords

Navigation